Date de publication: 21 septembre 2021
Promoteur – Intermédiaire Financier
SPINDIAG GMBHLieu
Description
The aim of the project is to improve the company's new COVID-19 PCR-based rapid test and to develop rapid tests against other infectious diseases, such as the ones caused by respiratory or antibiotic-resistant pathogens.
Objectifs
EIB financing will support and accelerate the research, development and innovation (RDI) efforts conducted by the Promoter to improve a new PCR-based diagnostic device and kit for rapid COVID-19 testing, as well as to develop fast, simple and reliable tests for other infectious diseases, targeting multiple pathogens, including the ones responsible for antimicrobial resistance.
Secteur(s)
- Industrie - Industrie manufacturière
Montant BEI envisagé (montant approximatif)
EUR 15 million
Coût total (montant approximatif)
EUR 33 million
Aspects environnementaux
The project concerns investments in research and development activities carried out by the Promoter in existing facilities already authorised for the same purpose and would therefore not require an environmental impact assessment (EIA) under the Directive 2014/52/EU amending the EIA Directive 2011/92/EU. Full environmental details will be verified during the appraisal by the EIB regarding the compliance of the project with the relevant European legislation.
Passation des marchés
The Promoter has been assessed by the EIB as being a private company not subject to EU rules on public procurement or concessions. However, if at the project appraisal, the EIB were to conclude that the Promoter is after all subject to the EU public procurement legislation (Directive 2014/24/EU, where applicable), then the Bank would require the Promoter to ensure that contracts for the implementation of the project will be tendered in accordance with the relevant applicable EU procurement legislation (Directive 2014/24/EU, where applicable, as well as Directive 89/665/EEC), as interpreted by the Court of Justice of the EU, with publication of tender notices in the Official Journal of the EU, as and where required.
Statut
Signé - 12/10/2022
Clause de non-responsabilité
Before financing approval by the Board of Directors, and before loan signature, projects are under appraisal and negotiation. The data provided on this page is therefore indicative and cannot be considered to represent official EIB policy (see also the Explanatory notes).